Catalysts for $COLL
120 tracked
Sep 18, 2018
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 18, 2018
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Sep 18, 2018
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Sep 18, 2018
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 18, 2018
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 18, 2018
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 18, 2018
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Aug 8, 2018
approval
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Nov 6, 2017
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
May 26, 2017
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
May 26, 2017
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Feb 28, 2017
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 24, 2017
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 4, 2017
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 4, 2017
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 4, 2017
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Dec 16, 2016
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 16, 2016
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Dec 16, 2016
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 16, 2016
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 30, 2016
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 30, 2016
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
May 27, 2016
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
May 13, 2016
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Apr 26, 2016
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Apr 20, 2016
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 4, 2015
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Sep 15, 2015
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jul 13, 2015
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jun 26, 2015
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→